Cargando…
Clinical characteristics and management outcomes of acute retinal necrosis
This study investigates patient’s clinical characteristics and management outcomes of PCR-positive Acute Retinal Necrosis (ARN). The patient’s clinical characteristics of the disease, and therapeutic approaches were assessed. Data from the medical records of 40 eyes of 40 patients were analyzed. The...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560224/ https://www.ncbi.nlm.nih.gov/pubmed/37805622 http://dx.doi.org/10.1038/s41598-023-44310-4 |
_version_ | 1785117685068070912 |
---|---|
author | Shiezadeh, Elham Hosseini, Seyedeh Maryam Bakhtiari, Elham Mojarrad, Alireza Motamed Shariati, Mehrdad |
author_facet | Shiezadeh, Elham Hosseini, Seyedeh Maryam Bakhtiari, Elham Mojarrad, Alireza Motamed Shariati, Mehrdad |
author_sort | Shiezadeh, Elham |
collection | PubMed |
description | This study investigates patient’s clinical characteristics and management outcomes of PCR-positive Acute Retinal Necrosis (ARN). The patient’s clinical characteristics of the disease, and therapeutic approaches were assessed. Data from the medical records of 40 eyes of 40 patients were analyzed. The mean ± standard deviation (SD) of the age of the patients was 47.8 ± 14.1 years (16–84 years old). The median follow-up time was 160 days, with a range of 120–370 days. The mean ± SD of patients' primary and final BCVA was 1.24 ± 0.78 and 1.08 ± 0.86 LogMAR, respectively. The final BCVA increased significantly after the treatment in the last follow-up period in patients who did not undergo PPV (p = 0.029). Although, vision changes were not statistically significant in patients who underwent PPV (p = 0.549). 75% of our patients had a positive aqueous PCR for VZV, and the second most common causative agents were CMV and HSV (10% for each). Besides, rhegmatogenous retinal detachment (RRD) occurred in 25% of our patients. Our analysis showed that the presenting visual acuity and RRD occurrence are the significant prognostic factors for final blindness in ARN. |
format | Online Article Text |
id | pubmed-10560224 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-105602242023-10-09 Clinical characteristics and management outcomes of acute retinal necrosis Shiezadeh, Elham Hosseini, Seyedeh Maryam Bakhtiari, Elham Mojarrad, Alireza Motamed Shariati, Mehrdad Sci Rep Article This study investigates patient’s clinical characteristics and management outcomes of PCR-positive Acute Retinal Necrosis (ARN). The patient’s clinical characteristics of the disease, and therapeutic approaches were assessed. Data from the medical records of 40 eyes of 40 patients were analyzed. The mean ± standard deviation (SD) of the age of the patients was 47.8 ± 14.1 years (16–84 years old). The median follow-up time was 160 days, with a range of 120–370 days. The mean ± SD of patients' primary and final BCVA was 1.24 ± 0.78 and 1.08 ± 0.86 LogMAR, respectively. The final BCVA increased significantly after the treatment in the last follow-up period in patients who did not undergo PPV (p = 0.029). Although, vision changes were not statistically significant in patients who underwent PPV (p = 0.549). 75% of our patients had a positive aqueous PCR for VZV, and the second most common causative agents were CMV and HSV (10% for each). Besides, rhegmatogenous retinal detachment (RRD) occurred in 25% of our patients. Our analysis showed that the presenting visual acuity and RRD occurrence are the significant prognostic factors for final blindness in ARN. Nature Publishing Group UK 2023-10-07 /pmc/articles/PMC10560224/ /pubmed/37805622 http://dx.doi.org/10.1038/s41598-023-44310-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Shiezadeh, Elham Hosseini, Seyedeh Maryam Bakhtiari, Elham Mojarrad, Alireza Motamed Shariati, Mehrdad Clinical characteristics and management outcomes of acute retinal necrosis |
title | Clinical characteristics and management outcomes of acute retinal necrosis |
title_full | Clinical characteristics and management outcomes of acute retinal necrosis |
title_fullStr | Clinical characteristics and management outcomes of acute retinal necrosis |
title_full_unstemmed | Clinical characteristics and management outcomes of acute retinal necrosis |
title_short | Clinical characteristics and management outcomes of acute retinal necrosis |
title_sort | clinical characteristics and management outcomes of acute retinal necrosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560224/ https://www.ncbi.nlm.nih.gov/pubmed/37805622 http://dx.doi.org/10.1038/s41598-023-44310-4 |
work_keys_str_mv | AT shiezadehelham clinicalcharacteristicsandmanagementoutcomesofacuteretinalnecrosis AT hosseiniseyedehmaryam clinicalcharacteristicsandmanagementoutcomesofacuteretinalnecrosis AT bakhtiarielham clinicalcharacteristicsandmanagementoutcomesofacuteretinalnecrosis AT mojarradalireza clinicalcharacteristicsandmanagementoutcomesofacuteretinalnecrosis AT motamedshariatimehrdad clinicalcharacteristicsandmanagementoutcomesofacuteretinalnecrosis |